Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Colorectal OmiCs and Oncofetal Chondroitin Sulfate-modified Proteoglycans

NCT06287671 is registered in ClinicalTrials.gov with Claus Anders Bertelsen, PhD, MD as lead sponsor.

NCT NCT06287671
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06287671 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Colorectal OmiCs and Oncofetal Chondroitin Sulfate-modified Proteoglycans
Lead sponsor
Claus Anders Bertelsen, PhD, MD
Phase
Observational
Overall status
Recruiting
Start date
October 8, 2024
Completion date
December 31, 2032
Enrollment
1,000 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer, diverticulitis, colonic, inflammatory bowel diseases, stoma colostomy